Your search returned 5 results.

Results
	1.	I-124 PET/CT versus conventional radioiodine imaging in differentiated thyroid cancer: a review. MedStar authors: Burman, Kenneth D Heimlich, S Layla Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Ylli, Dorina PMID: 31452449 Year: 2019 Citation: Thyroid. 29(11):1523-1535, 2019 11. Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Library Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Burman KD, Heimlich SL, Van Nostrand D, Wartofsky L, Wu D, Ylli D DOI: https://dx.doi.org/10.1089/thy.2018.0598 https://dx.doi.org/10.1089/thy.2018.0598 https://dx.doi.org/10.1089/thy.2018.0598 https://dx.doi.org/10.1089/thy.2018.0598 Add to cart (remove)
	2.	I-124 PET/CT image-based dosimetry in patients with differentiated thyroid cancer treated with I-131: correlation of patient-specific lesional dosimetry to treatment response. MedStar authors: Garcia, Carlos Plyku, Donika Van Nostrand, Douglas Wu, Di PMID: 35119623 Year: 2022 Citation: Annals of Nuclear Medicine. 36(3):213-223, 2022 Mar. Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Garcia C, Hobbs RF, Plyku D, Sgouros G, Van Nostrand D, Wu D DOI: https://dx.doi.org/10.1007/s12149-021-01655-y Add to cart (remove)
	3.	The spectrum of 124I uptake in the lacrimal gland and nasolacrimal sac/duct on PET/CT imaging. MedStar authors: Burman, Kenneth D Garcia, Carlos Kulkarni, Kanchan Plyku, Donika Van Nostrand, Douglas Wartofsky, Leonard Wu, Di PMID: 33323865 Year: 2021 Citation: Nuclear Medicine Communications. 42(3):292-299, 2021 Mar 01. Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Burman KD, Garcia C, Kulkarni K, Plyku D, Van Nostrand D, Wartofsky L, Wu D DOI: https://dx.doi.org/10.1097/MNM.0000000000001330 Add to cart (remove)
	4.	Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in 124I-PET/CT based dosimetry for 131I therapy of metastatic differentiated thyroid cancer. MedStar authors: Atkins, Francis Garcia, Carlos Van Nostrand, Douglas PMID: 28104741 Year: 2017 Citation: Journal of Nuclear Medicine. 58(7):1146-1154, 2017 Jul Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Atkins F, Garcia C, Hobbs RF, Huang K, Plyku D, Sgouros G, Van Nostrand D DOI: https://dx.doi.org/10.2967/jnumed.116.179366 Add to cart (remove)
	5.	Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in the identification of metastasis in differentiated thyroid cancer with 131I planar whole-body imaging and 124I PET.[Erratum appears in J Nucl Med. 2012 May;53(5):830] MedStar authors: Atkins, Frank B Burman, Kenneth D Chennupati, Shyam P Kharazi, Pejman Khorjekar, Gauri R Mete, Mihriye Moreau, Shari O'Neil, Jeff Van Nostrand, Douglas Wartofsky, Leonard PMID: 22315442 Year: 2012 Citation: Journal of Nuclear Medicine. 53(3):359-62, 2012 Mar. Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Journal Article Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Atkins FB, Burman KD, Chennupati SP, Kharazi P, Khorjekar GR, Mete M, Moreau S, O'Neil J, Van Nostrand D, Wartofsky L DOI: http://dx.doi.org/10.2967/jnumed.111.096016 Add to cart (remove)

Powered by Koha